{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T19:15:53Z","timestamp":1774552553517,"version":"3.50.1"},"reference-count":18,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,9,15]]},"DOI":"10.7759\/cureus.92379","type":"journal-article","created":{"date-parts":[[2025,9,15]],"date-time":"2025-09-15T16:33:18Z","timestamp":1757953998000},"source":"Crossref","is-referenced-by-count":1,"title":["Genotype-Phenotype Correlation and Psychiatric Manifestations in a Case of Phelan-McDermid Syndrome With 22q13.33 Deletion"],"prefix":"10.7759","author":[{"given":"Mario Alberto","family":"Puente Torres","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juan Jorge","family":"Palacios Casados","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yvonne","family":"Flores Medina","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aide\u00e9","family":"Gonzalez Gutierrez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carlos Sab\u00e1s","family":"Cruz Fuentes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"crossref","DOI":"10.3390\/genes13030504","article-title":"Clinical and genetic aspects of Phelan-McDermid syndrome: an interdisciplinary approach to management","volume":"13","author":"Cammarata-Scalisi F","year":"2022","unstructured":"Cammarata-Scalisi F, Callea M, Martinelli D, et al.. Clinical and genetic aspects of Phelan-McDermid syndrome: an interdisciplinary approach to management. Genes (Basel). 2022, 13:504.","journal-title":"Genes (Basel)"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmg.2020.104042","article-title":"Neurofibromatosis type 2 in Phelan-McDermid syndrome: institutional experience and review of the literature","volume":"63","author":"Ziats CA","year":"2020","unstructured":"Ziats CA, Jain L, McLarney B, et al.. Neurofibromatosis type 2 in Phelan-McDermid syndrome: institutional experience and review of the literature. Eur J Med Genet. 2020, 63:104042. 10.1016\/j.ejmg.2020.104042","journal-title":"Eur J Med Genet"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1111\/cge.14503","article-title":"Evidence for common mechanisms of pathology between SHANK3 and other genes of Phelan-McDermid syndrome","volume":"105","author":"Mitz AR","year":"2024","unstructured":"Mitz AR, Boccuto L, Thurm A. Evidence for common mechanisms of pathology between SHANK3 and other genes of Phelan-McDermid syndrome. Clin Genet. 2024, 105:459-69. 10.1111\/cge.14503","journal-title":"Clin Genet"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1002\/ajmg.a.63312","article-title":"Updated consensus guidelines on the management of Phelan-McDermid syndrome","volume":"191","author":"Srivastava S","year":"2023","unstructured":"Srivastava S, Sahin M, Buxbaum JD, et al.. Updated consensus guidelines on the management of Phelan-McDermid syndrome. Am J Med Genet A. 2023, 191:2015-44. 10.1002\/ajmg.a.63312","journal-title":"Am J Med Genet A"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpsychires.2017.03.010","article-title":"Characterizing regression in Phelan McDermid Syndrome (22q13 deletion syndrome)","volume":"91","author":"Reierson G","year":"2017","unstructured":"Reierson G, Bernstein J, Froehlich-Santino W, et al.. Characterizing regression in Phelan McDermid Syndrome (22q13 deletion syndrome). J Psychiatr Res. 2017, 91:139-44. 10.1016\/j.jpsychires.2017.03.010","journal-title":"J Psychiatr Res"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1097\/YCO.0000000000000672","article-title":"Recent developments in Phelan-McDermid syndrome research: an update on cognitive development, communication and psychiatric disorders","volume":"34","author":"Vogels A","year":"2021","unstructured":"Vogels A, Droogmans G, Vergaelen E, Van Buggenhout G, Swillen A. Recent developments in Phelan-McDermid syndrome research: an update on cognitive development, communication and psychiatric disorders. Curr Opin Psychiatry. 2021, 34:118-22. 10.1097\/YCO.0000000000000672","journal-title":"Curr Opin Psychiatry"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyt.2022.836807","article-title":"Understanding behavior in Phelan-McDermid syndrome","volume":"13","author":"Landlust AM","year":"2022","unstructured":"Landlust AM, Visser L, Flapper BC, Ruiter SA, Zwanenburg RJ, van Ravenswaaij-Arts CM, van Balkom ID. Understanding behavior in Phelan-McDermid syndrome. Front Psychiatry. 2022, 13:836807. 10.3389\/fpsyt.2022.836807","journal-title":"Front Psychiatry"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1017\/neu.2024.46","article-title":"Phelan-McDermid syndrome-associated psychosis: a systematic review","volume":"37","author":"Colijn MA","year":"2024","unstructured":"Colijn MA. Phelan-McDermid syndrome-associated psychosis: a systematic review. Acta Neuropsychiatr. 2024, 37:e15. 10.1017\/neu.2024.46","journal-title":"Acta Neuropsychiatr"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1080\/20473869.2020.1756113","article-title":"Case study: organizing outpatient pharmacological treatment of bipolar disorder in autism, intellectual disability and Phelan-McDermid syndrome (22q13.3 deletion syndrome)","volume":"68","author":"Rysstad AL","year":"2022","unstructured":"Rysstad AL, Kildahl AN, Skavhaug JO, D\u00f8nnum MS, Helverschou SB. Case study: organizing outpatient pharmacological treatment of bipolar disorder in autism, intellectual disability and Phelan-McDermid syndrome (22q13.3 deletion syndrome). Int J Dev Disabil. 2022, 68:378-87. 10.1080\/20473869.2020.1756113","journal-title":"Int J Dev Disabil"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1186\/s13229-019-0291-3","article-title":"Neuropsychiatric decompensation in adolescents and adults with Phelan-McDermid syndrome: a systematic review of the literature","volume":"10","author":"Kolevzon A","year":"2019","unstructured":"Kolevzon A, Delaby E, Berry-Kravis E, Buxbaum JD, Betancur C. Neuropsychiatric decompensation in adolescents and adults with Phelan-McDermid syndrome: a systematic review of the literature. Mol Autism. 2019, 10:50. 10.1186\/s13229-019-0291-3","journal-title":"Mol Autism"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1002\/ajmg.a.62222","article-title":"Genotype-phenotype correlation in Phelan-McDermid syndrome: a comprehensive review of chromosome 22q13 deleted genes","volume":"185","author":"Ricciardello A","year":"2021","unstructured":"Ricciardello A, Tomaiuolo P, Persico AM. Genotype-phenotype correlation in Phelan-McDermid syndrome: a comprehensive review of chromosome 22q13 deleted genes. Am J Med Genet A. 2021, 185:2211-33. 10.1002\/ajmg.a.62222","journal-title":"Am J Med Genet A"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.1005067","article-title":"Glial receptor PLXNB2 regulates schizophrenia-related stress perception via the amygdala","volume":"13","author":"Xuan FL","year":"2022","unstructured":"Xuan FL, Yan L, Li Y, et al.. Glial receptor PLXNB2 regulates schizophrenia-related stress perception via the amygdala. Front Immunol. 2022, 13:1005067. 10.3389\/fimmu.2022.1005067","journal-title":"Front Immunol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/j.cellsig.2019.06.008","article-title":"PLEXIN-B2 promotes the osteogenic differentiation of human bone marrow mesenchymal stem cells via activation of the RhoA signaling pathway","volume":"62","author":"Zhang Y","year":"2019","unstructured":"Zhang Y, Shen S, Li P, Fan Y, Zhang L, Li W, Liu Y. PLEXIN-B2 promotes the osteogenic differentiation of human bone marrow mesenchymal stem cells via activation of the RhoA signaling pathway. Cell Signal. 2019, 62:109343. 10.1016\/j.cellsig.2019.06.008","journal-title":"Cell Signal"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.3390\/genes14111998","article-title":"Brain gene co-expression network analysis identifies 22q13 region genes associated with autism, intellectual disability, seizures, language impairment, and hypotonia","volume":"14","author":"Shah S","year":"2023","unstructured":"Shah S, Sarasua SM, Boccuto L, Dean BC, Wang L. Brain gene co-expression network analysis identifies 22q13 region genes associated with autism, intellectual disability, seizures, language impairment, and hypotonia. Genes (Basel). 2023, 14:1998. 10.3390\/genes14111998","journal-title":"Genes (Basel)"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1016\/j.pediatrneurol.2021.06.002","article-title":"The neurological manifestations of Phelan-McDermid syndrome","volume":"122","author":"Frank Y","year":"2021","unstructured":"Frank Y. The neurological manifestations of Phelan-McDermid syndrome. Pediatr Neurol. 2021, 122:59-64. 10.1016\/j.pediatrneurol.2021.06.002","journal-title":"Pediatr Neurol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmg.2019.103751","article-title":"A longitudinal perspective on the pharmacotherapy of 24 adult patients with Phelan McDermid syndrome","volume":"63","author":"Verhoeven WM","year":"2020","unstructured":"Verhoeven WM, Egger JI, de Leeuw N. A longitudinal perspective on the pharmacotherapy of 24 adult patients with Phelan McDermid syndrome. Eur J Med Genet. 2020, 63:103751. 10.1016\/j.ejmg.2019.103751","journal-title":"Eur J Med Genet"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1093\/hmg\/ddab280","article-title":"Strong evidence for genotype-phenotype correlations in Phelan-McDermid syndrome: results from the developmental synaptopathies consortium","volume":"31","author":"Levy T","year":"2022","unstructured":"Levy T, Foss-Feig JH, Betancur C, et al.. Strong evidence for genotype-phenotype correlations in Phelan-McDermid syndrome: results from the developmental synaptopathies consortium. Hum Mol Genet. 2022, 31:625-37. 10.1093\/hmg\/ddab280","journal-title":"Hum Mol Genet"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1186\/s11689-020-9309-6","article-title":"Psychiatric illness and regression in individuals with Phelan-McDermid syndrome","volume":"12","author":"Kohlenberg TM","year":"2020","unstructured":"Kohlenberg TM, Trelles MP, McLarney B, Betancur C, Thurm A, Kolevzon A. Psychiatric illness and regression in individuals with Phelan-McDermid syndrome. J Neurodev Disord. 2020, 12:7. 10.1186\/s11689-020-9309-6","journal-title":"J Neurodev Disord"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/359437-genotype-phenotype-correlation-and-psychiatric-manifestations-in-a-case-of-phelan-mcdermid-syndrome-with-22q1333-deletion","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,15]],"date-time":"2025-09-15T16:33:19Z","timestamp":1757953999000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/359437-genotype-phenotype-correlation-and-psychiatric-manifestations-in-a-case-of-phelan-mcdermid-syndrome-with-22q1333-deletion"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,15]]},"references-count":18,"URL":"https:\/\/doi.org\/10.7759\/cureus.92379","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9,15]]}}}